|
Dr Krishna Ella, a distinguished scientist, co-founder and executive chairman of Bharat Biotech International, has been recognised with the prestigious India Fellowship of the Indian National Science Academy (INSA) for the year 2025, for his contributions to new knowledge, discoveries, development of new vaccine technologies, noteworthy improvement in existing technologies.
Dr Ella joins the list of distinguished scientists and industry leaders that include, Dr Anil Kakodkar, chairman of the Atomic Energy Commission of India, Dr VK Saraswat, former director general, DRDO, Dr S Somanath, chairman ISRO, S Kris Gopalakrishnan, co-founder, Infosys, Dr Samir V Kamat, secretary DDR&D and chairman, DRDO, Dr KN Sivarajan and luminaries from varied fields.
This year a total of 61 fellowships were awarded, for the first time ever, the fellowships were awarded to Industry leaders. Elected INSA fellows may attend and vote at INSA general meetings and can propose other individuals for fellowships or INSA awards.
“I deeply appreciate and I am thankful to be recognized for my contribution in the field of vaccines and biotechnology by INSA. I look forward to continuing to support its initiatives, to improve public health, and make India self-reliant and a dominant force in discovering novel vaccines as an Indian fellow,” Dr Krishna Ella, co-founder and executive chairman of Bharat Biotech said.
Speaking in his debut address at the 90th Anniversary General Meeting Indian National Science Academy held recently in Chennai, Dr Ella, highlighted "Science in Translation". He also thanked the Academy for the honour and reaffirmed his commitment to contribute to the goals and objectives through his endeavours through advancing vaccine science and strengthening the biotech ecosystem. Dr Ella’s fellowship recognition came for his pathbreaking vaccine development contributions. Indian National Science Academy (INSA).
Close to 3 decades, Bharat Biotech has been in the forefront of vaccine discovery, manufacturing and distribution having delivered more than 9 billion doses of vaccines to over 125 countries. The company has 18 vaccines in its portfolio.
|